The group’s two new Business Leaders, Emma Höglund and Pasi Korhonen, both have a proven track-record of scaling business internationally. Together, they bring five decades of combined healthcare and life sciences expertise to BCB.
Emma Höglund is appointed as the Head of Care Pathway Solutions, including a state-of-the-art Care Pathway Platform and innovative products, to allow BCB’s customers to integrate, structure and convert data into powerful insights. Emma Höglund joined BCB Group earlier in 2022 as the Chief of Growth.
She brings over 15 years of experience from both the healthcare industry (Sirona, Goldman Sachs) as well as international commercial roles in the life sciences industry (MSD/Merck & Co and Novartis).
Höglund has her training in Economics & Business Administration from the Stockholm School of Economics.
“I am excited to take on this new role in our crucial mission of improving care for patients and boosting healthcare productivity by simplifying everyday life for healthcare professionals. BCB Group is uniquely positioned to provide solutions at the juncture of healthcare, life sciences and academia, which will make a big difference to our customers and patients”, Höglund commented.
Pasi Korhonen is appointed as the Head of Data Solutions, including a leading AI-powered data and analytics product platform and leading analytics capabilities, to serve both health systems and global life science companies by converting clinical data into meaningful information.
Pasi Korhonen joined BCB Group as an advisor earlier in 2022. Korhonen is a serial entrepreneur, having successfully built data analytics companies in Real World Data and clinical trials space (StatFinn and EPID Research) that were acquired by IQVIA in 2018.
He brings over 30 years of experience in global Real World Data and clinical trial projects. He is also an Adjunct Professor in Biostatistics.
Korhonen commented on his new role: “I am looking forward to working with the BCB Group’s talented people who have built an impressive portfolio of care pathway solutions and data-driven technologies over the last 20 years. I am excited to assume this position and take on a journey to further build BCB’s Care Pathway Platform products and research knowledge into scalable data-driven solutions for global life science and health care customers. “
BCB Group’s market leading Care Pathway Platform drive value-based medicine and improve health outcomes in the most severe patient groups. The group also provides innovative data-driven solutions that improve healthcare efficiency and facilitate access to new medicines faster for patients.
Towards BCB Group’s international expansion
Patrik Sobocki, CEO of BCB Group, is delighted to welcome Höglund and Korhonen into their Business Leader roles: “I’m thrilled that Emma and Pasi assume their new roles, as their combined international leadership experience and deep healthcare and life sciences industry experience will serve BCB Group exceptionally well. BCB Group is ready for continued international growth, and Emma and Pasi will be there to guide our way to support global healthcare and life sciences industry to drive value-based medicine through technology and data insights.”
BCB Group’s two companies, BCB Medical and Health Solutions, form a leading HealthTech company serving both the international healthcare industry and global life sciences customers across Northern Europe.
The international growth of these two Nordic companies is supported by modern scalable software combined with data-driven solutions with a team of 100 experienced engineers, healthcare experts and data scientists. The merger between BCB Medical and Health Solutions was concluded in May 2021.
For more information:
Elina Matilainen
Head of Marketing and Communications
Contact Us
